Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Effect of vitamin K supplementation on bone loss in elderly men and women.

Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B.

J Clin Endocrinol Metab. 2008 Apr;93(4):1217-23. doi: 10.1210/jc.2007-2490.

2.

Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women.

Bolton-Smith C, McMurdo ME, Paterson CR, Mole PA, Harvey JM, Fenton ST, Prynne CJ, Mishra GD, Shearer MJ.

J Bone Miner Res. 2007 Apr;22(4):509-19.

3.

Effect of phylloquinone (vitamin K1) supplementation for 12 months on the indices of vitamin K status and bone health in adult patients with Crohn's disease.

O'Connor EM, Grealy G, McCarthy J, Desmond A, Craig O, Shanahan F, Cashman KD.

Br J Nutr. 2014 Oct 14;112(7):1163-74. doi: 10.1017/S0007114514001913.

PMID:
25181575
4.

Vitamin K, circulating cytokines, and bone mineral density in older men and women.

Shea MK, Dallal GE, Dawson-Hughes B, Ordovas JM, O'Donnell CJ, Gundberg CM, Peterson JW, Booth SL.

Am J Clin Nutr. 2008 Aug;88(2):356-63.

5.

Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.

Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R.

PLoS Med. 2008 Oct 14;5(10):e196. doi: 10.1371/journal.pmed.0050196. Erratum in: PLoS Med. 2008 Dec;5(12):e247.

6.

Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.

Binkley N, Harke J, Krueger D, Engelke J, Vallarta-Ast N, Gemar D, Checovich M, Chappell R, Suttie J.

J Bone Miner Res. 2009 Jun;24(6):983-91. doi: 10.1359/jbmr.081254.

7.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

8.

Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and phylloquinone (vitamin K(1)) or menaquinone-7 (vitamin K (2)): the Postmenopausal Health Study II.

Kanellakis S, Moschonis G, Tenta R, Schaafsma A, van den Heuvel EG, Papaioannou N, Lyritis G, Manios Y.

Calcif Tissue Int. 2012 Apr;90(4):251-62. doi: 10.1007/s00223-012-9571-z.

PMID:
22392526
9.

Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.

Kruger MC, Booth CL, Coad J, Schollum LM, Kuhn-Sherlock B, Shearer MJ.

Nutrition. 2006 Nov-Dec;22(11-12):1120-8.

PMID:
17030114
10.

Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women.

Bügel S, Sørensen AD, Hels O, Kristensen M, Vermeer C, Jakobsen J, Flynn A, Mølgaard C, Cashman KD.

Br J Nutr. 2007 Feb;97(2):373-80.

PMID:
17298708
11.

Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.

Braam LA, Knapen MH, Geusens P, Brouns F, Hamulyák K, Gerichhausen MJ, Vermeer C.

Calcif Tissue Int. 2003 Jul;73(1):21-6.

PMID:
14506950
12.

Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: comparison of younger and older adults.

Booth SL, O'Brien-Morse ME, Dallal GE, Davidson KW, Gundberg CM.

Am J Clin Nutr. 1999 Sep;70(3):368-77.

13.

Vitamin K, bone turnover, and bone mass in girls.

Kalkwarf HJ, Khoury JC, Bean J, Elliot JG.

Am J Clin Nutr. 2004 Oct;80(4):1075-80.

14.
15.
16.

The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial.

Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almås B, Jorde R.

Osteoporos Int. 2012 Jan;23(1):201-11. doi: 10.1007/s00198-011-1752-5.

PMID:
21909730
17.

Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K.

Truong JT, Fu X, Saltzman E, Al Rajabi A, Dallal GE, Gundberg CM, Booth SL.

J Nutr. 2012 May;142(5):936-41. doi: 10.3945/jn.111.154807.

18.

Vitamin K supplementation does not significantly impact bone mineral density and biochemical markers of bone in pre- and perimenopausal women.

Volpe SL, Leung MM, Giordano H.

Nutr Res. 2008 Sep;28(9):577-82. doi: 10.1016/j.nutres.2008.06.006.

PMID:
19083462
19.

Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.

Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E.

Osteoporos Int. 2013 Sep;24(9):2499-507. doi: 10.1007/s00198-013-2325-6.

PMID:
23525894
20.

Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.

Gallagher JC, Fowler SE, Detter JR, Sherman SS.

J Clin Endocrinol Metab. 2001 Aug;86(8):3618-28.

PMID:
11502787
Items per page

Supplemental Content

Support Center